Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.
- Louvet, Christophe
- André, Thierry
- Lledo, G
- Hammel, Pascal
- Bleiberg, Harry
- Bouleuc, C
- Gamelin, Eric
- Flesch, M
- Cvitkovic, Esteban
- de Gramont, Aimery
Publication date
March 2002
DOI Publisher
American Society of Clinical Oncology (ASCO) ISSN
0732-183XAbstract
Based on preclinical in vitro synergy data, this study evaluated the activity and toxicity of a gemcitabine/oxaliplatin combination in patients with metastatic and locally advanced pancreatic adenocarcinoma.Clinical TrialClinical Trial, Phase IIJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publishe
Add to ORKG